Investigation of the characteristics of medication errors and adverse drug reactions using pharmacovigilance data in China

被引:2
|
作者
Tan, Xiaofang [1 ]
Gu, Dongshi [1 ]
Lin, Xiaowen [2 ]
Fang, Huan [1 ]
Asakawa, Tetsuya [3 ,4 ]
机构
[1] Fudan Univ, Dept Pharm, Jinshan Hosp, 1508 Longhang Rd, Shanghai 201508, Peoples R China
[2] Jinshan Cent Hosp, Dept Pharm, 147 Jiankang Rd, Shanghai 201500, Peoples R China
[3] Hamamatsu Univ Sch Med, Dept Neurosurg, Hamamatsu, Shizuoka, Japan
[4] Fujian Univ Tradit Chinese Med, Res Base Tradit Chinese Med Syndrome, Fuzhou 350122, Peoples R China
基金
日本学术振兴会;
关键词
Medication errors; Adverse drug reactions; Spontaneous reporting; Adverse drug event; Pharmacovigilance; EVENTS; UNIT;
D O I
10.1016/j.jsps.2020.08.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to investigate the characteristics of medication errors (MEs) and adverse drug reactions (ADRs) using data from the spontaneous reporting system, which is helpful to understand the actual situation of MEs in China. Data from 2015 in a south distinct in Shanghai were gathered from the spontaneous reporting system and analyzed. The general information, cause of errors, severity, primary diseases, involved system and organs, symptoms, and suspected drugs were investigated. A total of 1290 adverse drug events (ADEs), including 1079 ADRs and 211 MEcs (MEs causing ADE), were reported. Older patients suffered from both ADRs and MEcs (age distribution and dosage form were different between ADRs and MEcs). The main causes of errors were inappropriate usage and dosage of drugs and inappropriate indication selection. Most ADR and MEc cases were mild; the possibility of developing a severe adverse event was quite low. The distribution of the top 10 system and organs, and symptoms involved was significantly different between ADRs and MEcs, with J01 drugs (antibacterials for systemic use) being the leading cause in both. Our results suggested that a direct analysis of data from the spontaneous reporting system is a reliable, and convenient method to investigate MEs and ADRs, despite the existing limitations, and contributes to further understanding the current situation of MEs and ADRs in China. (C) 2020 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.
引用
收藏
页码:1190 / 1196
页数:7
相关论文
共 50 条
  • [1] Underreporting Adverse Drug Reactions (ADR) and Medication Errors (ME): a Problem in Hospital Pharmacovigilance
    Garza-Ocanas, L.
    Escobedo Pena, J.
    Gonzalez-Nieto, C.
    Perez-Rodriguez, E.
    Guzman-Lopez, S.
    Aponte, E.
    Riojas-Hernandez, P.
    [J]. DRUG SAFETY, 2015, 38 (10) : 985 - 985
  • [2] Pharmacovigilance at a University Hospital: Strategies Developed for Increasing Adverse Drug Reactions and Medication Errors Reporting
    Garza-Ocanas, L.
    Perez-Rodriguez, E.
    Gonzalez-Nieto, C.
    Guzman-Lopez, S.
    [J]. DRUG SAFETY, 2014, 37 (10) : 848 - 849
  • [3] Adverse drug reactions to self-medication: a study in a pharmacovigilance database
    Berreni, Aurelia
    Montastruc, Francois
    Bondon-Guitton, Emmanuelle
    Rousseau, Vanessa
    Abadie, Delphine
    Durrieu, Genevieve
    Chebane, Leila
    Giroud, Jean-Paul
    Bagheri, Haleh
    Montastruc, Jean-Louis
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 (05) : 517 - 520
  • [4] Pharmacovigilance of sell-medication: a review of Adverse Drug Reactions (ADRs) registered in a pharmacovigilance database
    Berreni, A.
    Gunton, E.
    Rousseau, V.
    Abadie, D.
    Montastruc, F.
    Durrieu, G.
    Chebane, L.
    Giroud, J. P.
    Bagheri, H.
    Montastruc, J. L.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 49 - 50
  • [6] A Project on Adverse Drug Reactions Due to Medication Errors in Hospital
    Viola, E.
    Magro, L.
    Verlato, G.
    Finocchio, E.
    Leone, R.
    Velo, G. P.
    [J]. DRUG SAFETY, 2016, 39 (10) : 1025 - 1025
  • [8] An investigation of pharmacovigilance and reporting of adverse drug reactions in hospitals: a cross-sectional study in China
    Zhao, Zhigang
    Shen, Jiashu
    Shen, Chuanyong
    Zhu, Bin
    Sun, Jun
    Yu, Jinyang
    Sun, Feng
    Song, Haibo
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (11) : 2001 - 2006
  • [9] Pharmacovigilance and the reporting of adverse drug reactions
    Terblanche, Antoinette
    [J]. SA PHARMACEUTICAL JOURNAL, 2018, 85 (06) : 65 - 68
  • [10] Pharmacovigilance and Reporting Adverse Drug Reactions
    Isa, N. M.
    [J]. MEDICINE AND HEALTH-KUALA LUMPUR, 2014, 9 (02): : 92 - 102